Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)
Egypt flag Egypt · Delayed Price · Currency is EGP
3.630
+0.140 (4.01%)
At close: Jul 15, 2026

EGX:SIPC Income Statement

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
46.5254.8822.7813.3118.245.42
Revenue Growth (YoY)
41.43%140.93%71.17%-26.88%-59.93%-34.89%
Cost of Revenue
29.2232.8519.943.5110.8926.67
Gross Profit
17.322.032.849.87.3118.75
Selling, General & Admin
9.388.696.296.485.729.85
Other Operating Expenses
0.950.95-1.13-0.04--
Operating Expenses
10.339.6911.586.455.739.9
Operating Income
6.9612.34-8.743.341.588.85
Interest Expense
-1.89-2.11-1.65-1.05-1.07-0.65
Currency Exchange Gain (Loss)
-1.651.32-8.66-0.620-
Other Non Operating Income (Expenses)
---0.50.440.62
Pretax Income
3.4311.55-19.052.180.968.81
Income Tax Expense
1.31.47-0.571.020.942.03
Net Income
2.1310.08-18.491.160.026.78
Preferred Dividends & Other Adjustments
---0.1201.29
Net Income to Common
2.1310.08-18.491.040.015.49
Net Income Growth
---6280.77%-99.73%-55.22%
Shares Outstanding (Basic)
250250250250250250
Shares Outstanding (Diluted)
250250250250250250
EPS (Basic)
0.010.04-0.070.000.000.02
EPS (Diluted)
0.010.04-0.070.000.000.02
EPS Growth
---7075.86%-99.74%-
Free Cash Flow
1110.76-2.082.09-17.293.44
Free Cash Flow Per Share
0.040.04-0.010.01-0.070.01
Gross Margin
37.18%40.14%12.47%73.63%40.17%41.28%
Operating Margin
14.97%22.49%-38.38%25.13%8.70%19.48%
Profit Margin
4.57%18.37%-81.15%7.82%0.08%12.09%
Free Cash Flow Margin
23.64%19.60%-9.14%15.72%-94.97%7.57%
EBITDA
9.9815.84-5.656.565.412.06
EBITDA Margin
21.45%28.87%-24.80%49.31%29.68%26.55%
D&A For EBITDA
3.023.53.093.223.823.21
EBIT
6.9612.34-8.743.341.588.85
EBIT Margin
14.97%22.49%-38.38%25.13%8.70%19.48%
Effective Tax Rate
37.90%12.72%-46.88%98.11%23.04%
Advertising Expenses
--000.03-